Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Frank Holz

The Power List 2014


Frank Holz

Frank Holz is an AMD researcher whose focus is on the pathogenesis and therapy of AMD as well as on retinal imaging methodologies and phenotyping.  In addition, Holz has lead numerous ranibizumab clinical trials. He is Editor-in-Chief of the journal of the German Ophthalmological Society (DOG), Der Ophthalmologe, and a past president of DOG.


Part of the Power List 2014

The 100 most influential people

Who are the 100 most influential people in ophthalmology?
That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2014

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register